Baidu
map

Curr Eye Res:急性低血容量对眼睛的影响

2018-04-09 cuiguizhong MedSci原创

土耳其伊斯坦布尔卡努尼苏丹苏莱曼教育和研究医院眼科的Araz-Ersan HB近日在Curr Eye Res发表了一篇文章,他们探讨了献血引起的急性血容量不足对眼部的影响。

土耳其伊斯坦布尔卡努尼苏丹苏莱曼教育和研究医院眼科的Araz-Ersan HB近日在Curr Eye Res发表了一篇文章,他们探讨了献血引起的急性血容量不足对眼部的影响。

这是一项前瞻性观察性研究,其研究对象为48名年龄在20至40岁之间的健康男性的其中一只眼睛,他们都捐献了500毫升血液;其对照组是年龄和性别匹配的28位健康男性的28只眼睛。在献血前和在献血后10分钟以及第1、2、3和4小时,测量眼部参数,包括眼部灌注压(OPP)、眼内压(IOP)、轴向长度(AL)、中央角膜厚度(CCT)、脉络膜和视网膜厚度以及视网膜神经纤维层(RNFL)。

结果他们发现,献血后平均OPP显着降低(基线43.4±4.9比40.8±4.6 mmHg; p = 0.003)。在献血前、基线标准,献血后10分钟和1、2、3和4小时,平均中心凹下脉络膜厚度(SFCT)分别为322.96±76.23, 291.63±77.85, 309.77±75.72, 312.31±75.98, 315.73±75.43和317.75±75.73μm [F(2.462,115.731)= 22.618,p <0.001]。对照组在基线,10分钟和1,2,3和4时测量的SFCT分别为302.04±32.04, 301.43±35.16, 298.07±37.33, 298.96±39.17, 302.54±39.24和301.61±40.41μm [F(2.124,57.340)= 0.592,p = 0.566]。在献血前后AL、CCT、RNFL、视网膜厚度和IOP没有显着性差异(p> 0.05)。

因此,他们认为,急性低血容量导致SFCT显着降低,大约持续3小时。本研究可能为更好地了解疾病状态下脉络膜厚度变化铺平道路。

原文出处:

Araz-Ersan, H.B., et al., The Effect of Acute Hypovolemia on the Eye. Curr Eye Res, 2018: p. 1-6.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2040982, encodeId=c44a204098264, content=<a href='/topic/show?id=c37089010f7' target=_blank style='color:#2F92EE;'>#血容量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89010, encryptionId=c37089010f7, topicName=血容量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d521144, createdName=wrj0121, createdTime=Tue Jun 05 14:30:00 CST 2018, time=2018-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2029850, encodeId=76302029850ab, content=<a href='/topic/show?id=fedde18245' target=_blank style='color:#2F92EE;'>#eye#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7182, encryptionId=fedde18245, topicName=eye)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/7F67E3BE360D6DD1D0A62E3E71E23CB6/100, createdBy=9d8a2500148, createdName=ms8888626721583891, createdTime=Tue Sep 11 08:30:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304370, encodeId=7d673043e0ba, content=好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Tue Apr 10 06:53:09 CST 2018, time=2018-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304301, encodeId=b3d4304301c0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/30/21f1f0d02514796066d52523c747be51.jpg, createdBy=75a31960463, createdName=zdvfsadb, createdTime=Mon Apr 09 22:46:43 CST 2018, time=2018-04-09, status=1, ipAttribution=)]
    2018-06-05 wrj0121
  2. [GetPortalCommentsPageByObjectIdResponse(id=2040982, encodeId=c44a204098264, content=<a href='/topic/show?id=c37089010f7' target=_blank style='color:#2F92EE;'>#血容量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89010, encryptionId=c37089010f7, topicName=血容量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d521144, createdName=wrj0121, createdTime=Tue Jun 05 14:30:00 CST 2018, time=2018-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2029850, encodeId=76302029850ab, content=<a href='/topic/show?id=fedde18245' target=_blank style='color:#2F92EE;'>#eye#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7182, encryptionId=fedde18245, topicName=eye)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/7F67E3BE360D6DD1D0A62E3E71E23CB6/100, createdBy=9d8a2500148, createdName=ms8888626721583891, createdTime=Tue Sep 11 08:30:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304370, encodeId=7d673043e0ba, content=好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Tue Apr 10 06:53:09 CST 2018, time=2018-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304301, encodeId=b3d4304301c0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/30/21f1f0d02514796066d52523c747be51.jpg, createdBy=75a31960463, createdName=zdvfsadb, createdTime=Mon Apr 09 22:46:43 CST 2018, time=2018-04-09, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2040982, encodeId=c44a204098264, content=<a href='/topic/show?id=c37089010f7' target=_blank style='color:#2F92EE;'>#血容量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89010, encryptionId=c37089010f7, topicName=血容量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d521144, createdName=wrj0121, createdTime=Tue Jun 05 14:30:00 CST 2018, time=2018-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2029850, encodeId=76302029850ab, content=<a href='/topic/show?id=fedde18245' target=_blank style='color:#2F92EE;'>#eye#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7182, encryptionId=fedde18245, topicName=eye)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/7F67E3BE360D6DD1D0A62E3E71E23CB6/100, createdBy=9d8a2500148, createdName=ms8888626721583891, createdTime=Tue Sep 11 08:30:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304370, encodeId=7d673043e0ba, content=好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Tue Apr 10 06:53:09 CST 2018, time=2018-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304301, encodeId=b3d4304301c0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/30/21f1f0d02514796066d52523c747be51.jpg, createdBy=75a31960463, createdName=zdvfsadb, createdTime=Mon Apr 09 22:46:43 CST 2018, time=2018-04-09, status=1, ipAttribution=)]
    2018-04-10 张新亮1853311252142e2fm

    好文章学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2040982, encodeId=c44a204098264, content=<a href='/topic/show?id=c37089010f7' target=_blank style='color:#2F92EE;'>#血容量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89010, encryptionId=c37089010f7, topicName=血容量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d521144, createdName=wrj0121, createdTime=Tue Jun 05 14:30:00 CST 2018, time=2018-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2029850, encodeId=76302029850ab, content=<a href='/topic/show?id=fedde18245' target=_blank style='color:#2F92EE;'>#eye#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7182, encryptionId=fedde18245, topicName=eye)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/7F67E3BE360D6DD1D0A62E3E71E23CB6/100, createdBy=9d8a2500148, createdName=ms8888626721583891, createdTime=Tue Sep 11 08:30:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304370, encodeId=7d673043e0ba, content=好文章学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Tue Apr 10 06:53:09 CST 2018, time=2018-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=304301, encodeId=b3d4304301c0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/30/21f1f0d02514796066d52523c747be51.jpg, createdBy=75a31960463, createdName=zdvfsadb, createdTime=Mon Apr 09 22:46:43 CST 2018, time=2018-04-09, status=1, ipAttribution=)]
    2018-04-09 zdvfsadb

    学习了

    0

Baidu
map
Baidu
map
Baidu
map